title: Plasma sRAGE is independently associated with high sensitivity C-reactive protein in type 2 diabetes without coronary artery disease.
abstract: Our studies suggest that plasma soluble advanced glycation end products (sRAGEs) has significantly negative association with high sensitivity C-reactive protein (hs-CRP) in 245 type 2 diabetes patients without diagnosed coronary artery disease (CAD). sRAGE maybe act as a novel biomarker for predicting the atherosclerosis in diabetes at the early stage.
authors.affiliation: The Department of Endocrinology, Jiangsu Province Hospital of TCM, 155 Han-Zhong Road, Nanjing 210029, China.
authors.forename: Xiao-Fei
authors.initials: XF
authors.lastname: An
authors.forename: Yue
authors.initials: Y
authors.lastname: Zhao
authors.forename: Jiang-Yi
authors.initials: JY
authors.lastname: Yu
authors.forename: Jing-Shun
authors.initials: JS
authors.lastname: Liu
authors.forename: Wan-Jian
authors.initials: WJ
authors.lastname: Gu
authors.forename: Feng
authors.initials: F
authors.lastname: Gao
mesh_terms: D000368:Aged; D002097:C-Reactive Protein / Q000378:metabolism*; D003324:Coronary Artery Disease / Q000097:blood* / Q000150:complications; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000150:complications; D005260:Female; D017127:Glycation End Products, Advanced / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012044:Regression Analysis
chemical_list: D017127:Glycation End Products, Advanced; D002097:C-Reactive Protein